Abstract Submission
We invite clinicians, researchers, and professionals to submit abstracts for oral presentations at the CaReMeLO Conference, focusing on enhancing the role of primary care in managing CaReMeLO syndrome. Submitted abstracts will undergo peer review by the Abstract Review Committee and may be accepted for an oral presentation or rejected.
PRESENTATION TYPES AVAILABLE:
- ORAL PRESENTATION
ABSTRACT TOPICS:
- OPTIMIZING MULTIDISCIPLINARY CARE MODELS
- EARLY DETECTION AND INTERVENTION STRATEGIES
- INNOVATIONS IN MANAGING CARDIORENAL, METABOLIC, OR OBESITY-RELATED CHALLENGES
- PRACTICAL IMPLEMENTATION OF GUIDELINES IN PRIMARY CARE
- CASE STUDIES HIGHLIGHTING SUCCESSES AND CHALLENGES
- OTHER
*To better understand the scope of the topics, please make sure to familiarize yourself with the Program Highlights.
GUIDELINES FOR SUBMISSION:
- All abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university scientific publications office (or other similar facility) or by a copy editor, prior to submission.
- Abstracts must be submitted via the website only.
- Abstracts submitted by email will not be accepted.
- Please do not submit multiple copies of the same abstract.
- Abstracts must be received by the announced deadline. Please note: after the submission deadline abstracts cannot be modified or corrected.
- Each person may submit up to 2 abstracts.
- All abstracts will be forwarded to the Scientific Committee for review.
- You will receive confirmation that your abstract has been received, indicating the abstract number which it has been allocated. Please refer to this abstract number in all correspondence regarding this abstract.
- Please contact the Congress Secretariat if you have not received confirmation that your abstract has been received at reg_caremelo25@kenes.com
- Presenting authors must be registered participants. Authors of Abstracts will receive a registration deadline via email together with the status of their submission. Only authors who have paid their registration fees before the indicated date will be scheduled in the program.
- Presenting author can be replaced by one of the co-authors only.
- Abstracts that have been presented at another meeting may be submitted.
- Notifications regarding the status of the abstract will be sent once the review process is complete.
- No changes will be made to submitted and accepted abstracts.
- Conflicts of Interest / Disclosure: Abstract submitters will be requested to confirm that you will declare any conflict of interests in your presentation at the Congress.
Kindly note that the CaReMeLo Conference is accepting abstracts only for Oral Presentation.
RULES FOR SUBMISSION:
Before you begin, kindly prepare the following information:
Presenting Author contact information:
- Email address
- Full postal address
- Daytime and evening phone number
- Author and co-authors’ details
- Full first and family name(s)
- Authors’ names must be in upper and lower case (J.C.C. Smith)
- Affiliation information: department, institution / hospital, city state (if relevant), country
- Abstract title – Limited to 25 words in UPPER CASE
- Abstract text – Limited to 300 words. We recommend using word-processing software (for example, Word) for editing your abstract and counting the number of words.
- Abstract structure – Background, Methods, Results, and Conclusion.
- Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word the first time it appears.
- Use generic names of drugs. Express numbers as numerals.
- You will receive an abstract reference number via email after you have submitted your abstract.
- After the deadline, no changes will be accepted.
- Abstract topic – abstracts must be allocated to a specific topic for the scientific programme. You will need to select the topic most suited to your abstract.
ABSTRACT SUBMITTERS’ DECLARATION:
Disclosure of financial relationships that the author(s) may have with the manufacturer/supplier of any commercial products or services related to the work, should be indicated in the appropriate box on the abstract form.
The presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission.
The Organizers reserve the right to remove from any publications an abstract which does not comply with the above.